Shoulder Innovations, Inc. (SI)

NYQ – Цена в реальном времени. Валюта: USD

14.60

+0.19 (1.32%)

При закрытии: Mar 24, 2026, 4:00 PM EDT

01.09.2026

Shoulder Innovations to Participate in the Morgan Stanley 24th Annual Healthcare Conference

GRAND RAPIDS, Mich., Sept. 1, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced that members of management will participate in a fireside chat at the Morgan Stanley 24th Annual Healthcare Conference.

10.08.2026

Shoulder Innovations Promotes Jon Osborne to Chief Commercial Officer

GRAND RAPIDS, Mich., Aug. 10, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced the promotion of Jon Osborne to Chief Commercial Officer, effective August 6, 2026.

09.08.2026

Shoulder Innovations Q2 Earnings Call Highlights

Shoulder Innovations NYSE: SI reported second-quarter net revenue of $17.2 million, up 56% from $11 million a year earlier, as the company added surgeons, expanded use among existing customers and advanced several product launches. The company raised its full-year 2026 revenue outlook to $67 million to $69 million, from a prior range of $65 million to $68 million.

07.08.2026

Shoulder Innovations, Inc. (SI) Q2 2026 Earnings Call Transcript

07.08.2026

Shoulder Innovations, Inc. (SI) Reports Q2 Loss, Beats Revenue Estimates

Shoulder Innovations, Inc. (SI) came out with a quarterly loss of $0.46 per share in line with the Zacks Consensus Estimate. This compares to a loss of $64.47 per share a year ago.

06.08.2026

Shoulder Innovations Reports Second Quarter 2026 Financial Results and Raises Full Year Outlook

Generates First Half 2026 Revenue Growth of 60% GRAND RAPIDS, Mich., Aug. 6, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today reported financial results for the second quarter ended June 30, 2026.

Видео

No Data

There is no data to display

Повышения / Понижения рейтинга

Тикер	Фирма	Изменение рейтинга	Целевая цена	Дата
SI	UBS	Buy	undefined >> $27	July 28th 2026

Пресс-релизы

01.09.2026

Shoulder Innovations to Participate in the Morgan Stanley 24th Annual Healthcare Conference

10.08.2026

Shoulder Innovations Promotes Jon Osborne to Chief Commercial Officer

06.08.2026

Shoulder Innovations, Inc. (SI)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Shoulder Innovations, Inc. (SI)

Shoulder Innovations to Participate in the Morgan Stanley 24th Annual Healthcare Conference

Shoulder Innovations Promotes Jon Osborne to Chief Commercial Officer

Shoulder Innovations Q2 Earnings Call Highlights

Shoulder Innovations, Inc. (SI) Q2 2026 Earnings Call Transcript

Shoulder Innovations, Inc. (SI) Reports Q2 Loss, Beats Revenue Estimates

Shoulder Innovations Reports Second Quarter 2026 Financial Results and Raises Full Year Outlook

Видео

No Data

Повышения / Понижения рейтинга

Пресс-релизы

Shoulder Innovations to Participate in the Morgan Stanley 24th Annual Healthcare Conference

Shoulder Innovations Promotes Jon Osborne to Chief Commercial Officer

Shoulder Innovations Reports Second Quarter 2026 Financial Results and Raises Full Year Outlook

Shoulder Innovations to Participate in the Morgan Stanley 24th Annual Healthcare Conference

Shoulder Innovations Promotes Jon Osborne to Chief Commercial Officer

Shoulder Innovations Q2 Earnings Call Highlights

Shoulder Innovations, Inc. (SI) Q2 2026 Earnings Call Transcript

Shoulder Innovations, Inc. (SI) Reports Q2 Loss, Beats Revenue Estimates

Shoulder Innovations Reports Second Quarter 2026 Financial Results and Raises Full Year Outlook

Видео

No Data

Повышения / Понижения рейтинга

Пресс-релизы

Shoulder Innovations to Participate in the Morgan Stanley 24th Annual Healthcare Conference

Shoulder Innovations Promotes Jon Osborne to Chief Commercial Officer

Shoulder Innovations Reports Second Quarter 2026 Financial Results and Raises Full Year Outlook

Search stocks

Shoulder Innovations, Inc. (SI)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Shoulder Innovations, Inc. (SI)

Shoulder Innovations to Participate in the Morgan Stanley 24th Annual Healthcare Conference

Shoulder Innovations Promotes Jon Osborne to Chief Commercial Officer

Shoulder Innovations Q2 Earnings Call Highlights

Shoulder Innovations, Inc. (SI) Q2 2026 Earnings Call Transcript

Shoulder Innovations, Inc. (SI) Reports Q2 Loss, Beats Revenue Estimates

Shoulder Innovations Reports Second Quarter 2026 Financial Results and Raises Full Year Outlook

Видео

No Data

Повышения / Понижения рейтинга

Пресс-релизы

Shoulder Innovations to Participate in the Morgan Stanley 24th Annual Healthcare Conference

Shoulder Innovations Promotes Jon Osborne to Chief Commercial Officer

Shoulder Innovations Reports Second Quarter 2026 Financial Results and Raises Full Year Outlook

Shoulder Innovations to Participate in the Morgan Stanley 24th Annual Healthcare Conference

Shoulder Innovations Promotes Jon Osborne to Chief Commercial Officer

Shoulder Innovations Q2 Earnings Call Highlights

Shoulder Innovations, Inc. (SI) Q2 2026 Earnings Call Transcript

Shoulder Innovations, Inc. (SI) Reports Q2 Loss, Beats Revenue Estimates

Shoulder Innovations Reports Second Quarter 2026 Financial Results and Raises Full Year Outlook

Видео

No Data

Повышения / Понижения рейтинга

Пресс-релизы

Shoulder Innovations to Participate in the Morgan Stanley 24th Annual Healthcare Conference

Shoulder Innovations Promotes Jon Osborne to Chief Commercial Officer

Shoulder Innovations Reports Second Quarter 2026 Financial Results and Raises Full Year Outlook